Abbvie Biotechnology, Ltd. v. United States
Abbvie Biotechnology, Ltd. v. United States
Opinion
NOTE: This disposition is nonprecedential.
United States Court of Appeals for the Federal Circuit ______________________ ABBVIE BIOTECHNOLOGY, LTD., Appellant v. UNITED STATES, ANDREI IANCU, UNDER SECRETARY OF COMMERCE FOR INTELLECTUAL PROPERTY AND DIRECTOR OF THE UNITED STATES PATENT AND TRADEMARK OFFICE, Intervenors ______________________ 2017-2304, 2017-2305, 2017-2306, 2017-2362, 2017-2363 ______________________ Appeals from the United States Patent and Trademark Office, Patent Trial and Appeal Board in Nos. IPR2016- 00172, IPR2016-00188, IPR2016-00189, IPR2016-00408, IPR2016-00409.
______________________ JUDGMENT ______________________ THOMAS SAUNDERS, Wilmer Cutler Pickering Hale and Dorr LLP, Washington, DC, argued for appellant. Also rep- resented by WILLIAM G. MCELWAIN, AMY K. WIGMORE, DAVID P. YIN; WILLIAM F. LEE, Boston, MA; WILLIAM BARRETT RAICH, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, Washington, DC; CHARLES E. LIPSEY, STEVEN O'CONNOR, Reston, VA. NICHOLAS THEODORE MATICH, IV, Office of the Solicitor, United States Patent and Trademark Office, Alexandria, VA, argued for intervenors. Also represented by THOMAS W. KRAUSE, JOSEPH MATAL, MEREDITH HOPE SCHOENFELD, KAKOLI CAPRIHAN; DENNIS FAN, JOSEPH H. HUNT, SCOTT R. MCINTOSH, Appellate Staff, Civil Division, United States Department of Justice, Washington, DC. ______________________ THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED: PER CURIAM (DYK, O’MALLEY, and CHEN, Circuit Judges).
AFFIRMED. See Fed. Cir. R. 36.
ENTERED BY ORDER OF THE COURT
January 7, 2020 /s/ Peter R. Marksteiner Date Peter R. Marksteiner Clerk of Court
Case-law data current through December 31, 2025. Source: CourtListener bulk data.